Infectious disease

Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections: Surveillance, 2015-2016

From April 1, 2015, to March 31, 2016, 89 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,851,752 inpatient days (Table 1). Together, these facilities reported 65 cases of healthcare-associated MRSA bloodstream infections (HA-MRSA-BSI). The incidence rate was 0.13 per 10,000 patient-days. This incidence rate of HA-MRSA-BSI has……

Monitoring report

Interim Measures to Prevent and Control Transmission of Carbapenemase-producing Enterobacteriaceae and other Multidrug-Resistant Gram-Negative Bacilli in Long-term Care Settings

In 2010, the Comité sur les infections nosocomiales du Québec (CINQ) [Québec healthcare-associated infections committee] released its guidelines for preventing and controlling transmission of carbapenemase-producing Enterobacteriaceae, and then more recently, in 2015, its measures to prevent and control transmission of multidrug-resistant Gram-negative bacilli (MDR-GNB) in acute care settings.

The application of infection prevention and control (IPC) measures in long-term care…

Professional practice guidelines

Carbapenemase-Producing Gram Negative Bacilli (CPGNB) Infections - surveillance 2015-2016

From April 1, 2015, to March 31, 2016, 73 healthcare facilities took part in the surveillance of carbapenemase-producing Gram negative bacilli (CPGNB) infections, for a total of 3,749,277 patient days (Table 1). In total, four CPGNB infections were reported among patients who acquired their strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated CPGNB infection (cat. 1a and 1b) was 0.011 per 10,000…

Monitoring report

Vascular Access–Related Bloodstream Infections in Hemodialysis Patients: surveillance 2015-2016

From April 1st, 2015, to March 31st, 2016, 45 hemodialysis units took part in the surveillance of vascular access–related bloodstream infections (VARBSIs) in hemodialysis (HD) patients, for a combined total of 54,717 patient-periods (Table 1), slightly less than the preceding year. Participating units reported 136 VARBSIs in 129 patients. Patient-periods involving a fistula account for 41.0% of patient-periods. The 2015-2016…

Monitoring report

Vancomycin-Resistant Enterococci (VRE) Infections - Surveillance results: 2015-2016

From April 1, 2015, to March 31, 2016, 89 healthcare facilities took part in the surveillance of healthcare-associated vancomycin-resistant enterococci (VRE) infections, for a combined total of 4,833,086 patient days (Table 1). In total, 78 VRE infections were reported among patients who contracted strain during a current or previous hospital stay in the reporting facility (categories 1a and 1b). The incidence rate of healthcare-associated VRE infection (cat. 1a and 1b) was 0.16 per 10…

Monitoring report

Hospital-Wide Healthcare-associated Bloodstream Infections: surveillance 2015-2016

From April 1st, 2015, to March 31st, 2016, 87 healthcare facilities took part in the hospital-wide surveillance of bloodstream infections (BSIs), for a combined total of 4,770,053 patient-days (Table 1). Participating facilities reported 3,173 BSIs in 2,948 patients. The total 2015-2016 incidence rate is 5.45 cases per 10,000 patient-days for all facilities participating in 2015-2016, and it is 5.35 for facilities…

Monitoring report

Clostridium difficile–Associated Diarrhea: surveillance 2015-2016

From April 1, 2015, to March 31, 2016, 95 healthcare facilities participated in the Clostridium difficile–associated diarrhea (CDAD) surveillance program, for a combined total of 5,048,411 inpatient days (Table 1). These participating facilities reported 2,977 cases of healthcare-associated CDAD (HA-CDAD). The incidence rate of HA-CDAD was 5.9 cases per 10,000 patient days. The 2015-2016 incidence rate was significantly lower than……

Monitoring report

Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections: Surveillance, 2015-2016

From April 1, 2015, to March 31, 2016, 89 healthcare facilities participated in the surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections, for a combined total of 4,851,752 inpatient days (Table 1). Together, these facilities reported 65 cases of healthcare-associated MRSA bloodstream infections (HA-MRSA-BSI). The incidence rate was 0.13 per 10,000 patient-days. This incidence rate of HA-MRSA-BSI has……

Monitoring report

Risk Assessment: Emergence and Vector-borne Transmission of Zika Virus in Québec

Zika virus emerged in the Americas in 2015 and has since expanded its geographical range significantly. Currently, the virus is transmitted locally in 35 countries of the Caribbean, Central America and South America.

Zika virus infection is benign: 70 to 80% of patients have no symptoms, whereas 20% have a fever and rash accompanied by arthralgia and myalgia, conjunctivitis, headache, retro-orbital pain and fatigue.

Zika virus infection can cause neurological…

Scientific advisory

Central Line–Associated Bloodstream Infections in Intensive Care Units: Surveillance 2015-2016

From April 1st, 2015, to March 31st, 2016, 66 intensive care units (ICUs) took part in surveillance of central line–associated bloodstream infections (CLABSIs), for a combined total of 128,035 catheter-days (Table 1). Participating ICUs reported 150 CLABSIs in 139 patients. Incidence rates are 0.70 per 1,000 catheter-days in teaching adult ICUs, 0.42 in non-teaching adult ICUs, 1.95 in pediatric ICUs and 4.15 in neonatal ICUs…

Monitoring report